Loading…
ICON Public Limited Company is projected to rise to $218.10 by 2027, a +30% move from its current price of $167.72. ICLR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $163.34 | $167.83 | $172.45 | +0.07% |
| Jul 13 | $161.62 | $167.94 | $174.51 | +0.13% |
| Jul 14 | $160.34 | $168.06 | $176.14 | +0.20% |
| Jul 15 | $159.29 | $168.17 | $177.54 | +0.27% |
| Jul 16 | $158.38 | $168.28 | $178.80 | +0.34% |
| Jul 17 | $157.57 | $168.39 | $179.96 | +0.40% |
| Jul 18 | $156.84 | $168.51 | $181.04 | +0.47% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $156.84 | $168.51 | $181.04 | +0.47% |
| Week 2 | $152.96 | $169.30 | $187.38 | +0.94% |
| Week 3 | $150.21 | $170.09 | $192.61 | +1.42% |
| Week 4 | $148.04 | $170.89 | $197.27 | +1.89% |
| Week 5 | $146.24 | $171.69 | $201.58 | +2.37% |
| Week 6 | $144.69 | $172.50 | $205.65 | +2.85% |
| Week 7 | $143.34 | $173.31 | $209.55 | +3.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ICON Public Limited Company is a healthcare-focused clinical research organization that provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. ICON was incorporated in 1989 and is headquartered in Dublin, Ireland.
It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations, and has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model.
ICON offers clinical development services across all phases of development, peri and post approval, data solutions, site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. It also provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers.
The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations, and has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model.
ICON Public Limited Company (ICLR) is a healthcare stock with a current price of $169.86 and a market capitalization of $13.01B. It ranks 777 in market capitalization terms.
The stock’s technical backdrop shows bullish momentum on the near term, supported by a 30-day technical picture that aligns with an upside outlook. The 30-day range spans from $135.36 to $213.15, with immediate resistance at $169.86 and support around $113.55.
Looking at the long-run picture, the forecast paints a rising path for the price with a neutral stance in 2026 giving way to broad bullish momentum through 2027–2050. The model assigns a 2026 average of $169.86 (min $80.08, max $245.08) and an average price trajectory that climbs to $442.07 by 2030, $1,821.13 by 2040, and $3,502.01 by 2050, paired with substantial ROIs throughout the period.
A major floor 42.1% below — a decisive break under it would weaken the trend.
The nearest floor, 18.9% below — buyers have tended to step in here.
The nearest ceiling, 4.4% above — a clean break opens room to run.
A major ceiling 18.4% above — clearing it would confirm fresh momentum.
Key ICLR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICLR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $168.32 | Sell | $168.32 | Sell |
| MA 10 | $170.63 | Sell | $166.73 | Buy |
| MA 20 | $159.27 | Buy | $160.35 | Buy |
| MA 50 | $139.66 | Buy | $145.53 | Buy |
| MA 100 | $122.68 | Buy | $139.75 | Buy |
| MA 200 | $149.07 | Buy | $146.37 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.42 | Neutral |
| Stoch RSI (14) | 42.96 | Neutral |
| CCI (20) | 48.86 | Neutral |
| Williams %R (14) | -21.36 | Info |
| MACD (12,26,9) | -0.61 | Sell |
| ROC (12) | 17.56 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 78.64 | Neutral |
| TRIX (15) | 0.99 | Buy |
| Awesome (5,34) | 18.49 | Buy |
| Ultimate (7,14,28) | 46.79 | Neutral |
| Momentum (10) | 6.76 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 166.01 | Buy |
| ADX (14) | 31.93 | Buy |
| ATR (14) | 3.38 | Info |
In the 30-day frame, sentiment is bullish with RSI14 at 70, indicating strong momentum.
The stock trades above the 50-day moving average of $128.87 and below the 200-day moving average of $149.18, illustrating a positive near-term trajectory relative to medium-term trend. Key levels to watch are a support at $113.55 and a resistance at $169.86, defining a near-term trading band.
The 30-day price range runs from $135.36 to $213.15, pointing to a broad fluctuation band that could shape short-term movements depending on catalysts.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $80.08 | $167.72 | $226.41 | 0% | Neutral | |
| $173.73 | $218.10 | $289.62 | +30% | Bullish | |
| $219.13 | $282.82 | $389.60 | +69% | Bullish | |
| $262.26 | $346.34 | $491.01 | +107% | Bullish | |
| $269.12 | $362.67 | $526.75 | +116% | Bullish | |
| $292.96 | $402.15 | $596.58 | +140% | Bullish | |
| $326.22 | $455.56 | $688.73 | +172% | Bullish | |
| $353.52 | $501.71 | $771.61 | +199% | Bullish | |
| $434.37 | $625.95 | $978.01 | +273% | Bullish | |
| $490.40 | $717.13 | $1,137.01 | +328% | Bullish | |
| $727.38 | $1,136.72 | $1,916.48 | +578% | Bullish | |
| $1,228.46 | $2,152.19 | $3,968.40 | +11.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $80.08 | $167.72 | $199.94 | +0.00% |
| August 2026 | $146.34 | $172.72 | $209.35 | +2.98% |
| September 2026 | $150.00 | $178.27 | $218.46 | +3.21% |
| October 2026 | $147.11 | $175.88 | $217.53 | -1.34% |
| November 2026 | $145.00 | $174.24 | $217.18 | -0.93% |
| December 2026 | $149.39 | $180.36 | $226.41 | +3.51% |
Click any year to see its month-by-month ICLR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ICLR is projected to trade between $80.08 and $226.41, averaging $167.72 — a potential gain of 0% from today's $167.72. A consolidation phase looks the most probable path here.
ICON Public Limited Company's 2027 outlook centres on $218.10, within a $173.73 to $289.62 range. That is up +30% on the projected 2026 average. That marks a +30% change versus current levels. Momentum favours further upside here.
By 2028, ICLR could reach as high as $389.60, with a base case around $282.82 and support toward $219.13 — roughly +69% from $167.72. Buyers look set to stay in control over this stretch.
Expect ICLR to range from $262.26 to $491.01 through 2029. The $346.34 average target implies a +107% move from current prices. That is up +22% on the projected 2028 average. Momentum favours further upside here.
The ICLR price prediction for 2030 points to an average of $362.67 (low $269.12, high $526.75) — a potential gain of +116% on today's $167.72. Buyers look set to stay in control over this stretch.
In 2031, ICLR is projected to trade between $292.96 and $596.58, averaging $402.15 — a potential gain of +140% from today's $167.72. That is up +11% on the projected 2030 average. Momentum favours further upside here.
ICON Public Limited Company's 2032 outlook centres on $455.56, within a $326.22 to $688.73 range. That is up +13% on the projected 2031 average. That marks a +172% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ICLR could reach as high as $771.61, with a base case around $501.71 and support toward $353.52 — roughly +199% from $167.72. Momentum favours further upside here.
Expect ICLR to range from $434.37 to $978.01 through 2034. The $625.95 average target implies a +273% move from current prices. That is up +25% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ICLR price prediction for 2035 points to an average of $717.13 (low $490.40, high $1,137.01) — a potential gain of +328% on today's $167.72. Momentum favours further upside here.
In 2040, ICLR is projected to trade between $727.38 and $1,916.48, averaging $1,136.72 — a potential gain of +578% from today's $167.72. That is up +59% on the projected 2035 average. Buyers look set to stay in control over this stretch.
ICON Public Limited Company's 2050 outlook centres on $2,152.19, within a $1,228.46 to $3,968.40 range. That is up +89% on the projected 2040 average. That marks a +11.8x change versus current levels. Momentum favours further upside here.
Investing $1,000 in ICLR today (≈ 5.962318 ICLR) could be worth
$12,832.04
+$11,832.04 (+1183%) by 2050 · US Dollar
Based on the average projected ICLR price of $2,152.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICLRwould be worth at today's price.
$1,000 invested in ICLR on Jul 10, 2025 (≈ 6.575919 ICLR) would be worth
$1,102.91
+$102.91 (+10.3%) today · 1.10× · US Dollar
Based on a ICLR entry price of $152.07 vs. today's $167.72.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $173.06 | $969.14 | -3.1% |
| 1 month ago | $144.59 | $1,159.97 | +16.0% |
| 3 months ago | $106.81 | $1,570.26 | +57.0% |
| 6 months ago | $180.15 | $931 | -6.9% |
| 1 year ago | $152.07 | $1,102.91 | +10.3% |
| All time (5.0y) ago | $208.53 | $804.3 | -19.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICLR forecast.
Our base-case forecast reaches $340.00 around 2029.
Implied market cap at $340.00: $26.23B
The multi-year forecast shows persistent bullish sentiment from 2027 onward, with 2027’s average price at $244.59 and a 44% ROI, followed by 2028 at $338.67 (99.4% ROI) and 2029 at $428.80 (152.4% ROI). By 2030, the average is projected to $442.07 with a 160.3% ROI, and 2031–2035 continue the ascent with higher ROIs (e.g., 2021 202% and 2032 255.6% to 2033 294.5%). The forecast accelerates through 2034 ($901.98 avg, 431% ROI) and 2035 ($1,051.45 avg, 519% ROI).
Beyond the mid-2030s, the path strengthens dramatically: 2040’s average price is $1,821.13 with a 972.1% ROI and 2050’s average price is $3,502.01 with a 1961.7% ROI. Sentiment over the later years remains bullish. These numbers are estimates, not guarantees, and subject to market risk and other factors.
Tap a question to reveal the answer.
The forecast shows an average price of $442.07 by 2030, with a minimum of $312.48 and a maximum of $677.67; the ROI is 160.3%, and the sentiment is BULLISH.
The forecast shows bullish sentiment from 2027 onward, with averages rising to $244.59 in 2027 and up to $3,502.01 in 2050. ROIs are 44% in 2027, 99.4% in 2028, 152.4% in 2029, and 1961.7% in 2050. These are estimates, not guarantees.
Yes—the forecast max for 2033 is $1,099.75, and the max for 2034 is $1,508.25, indicating potential to clear $1,000.
Current price is $169.86 and market cap is $13.01B. ICON ranks 777.
The 30-day picture is bullish, with RSI 14 at 70, SMA50 at $128.87, and SMA200 at $149.18. Support is $113.55 and resistance is $169.86, with a 30-day range from $135.36 to $213.15.
ICON Public Limited Company Community Discussion
0Share your ICON Public Limited Company price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.